Naropin
Active Ingredient(s): RopivacaineFDA Approved: * September 24, 1996
Pharm Company: * ASTRAZENECA
Category: Anesthetic
Ropivacaine (rINN) /ropvken/ is a local anaesthetic drug belonging to the amino amide group. The name ropivacaine refers to both the racemate and the marketed S-enantiomer. Ropivacaine hydrochloride is commonly marketed by AstraZeneca under the brand name Naropin. Contents 1 History 2 Clinical use 2.1 Contraindications 2.2 Adverse effects 2.3 Postarthroscopic glenohumeral chondrolysis 2.4 Treatment of overdose 3 References 4 External links History Ropivacaine was developed after bup... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Naropin 5 mg/ml Epidural; Infiltration; Perineural Injection, Solution
NDC: 0404-9924
Labeler:
Henry Schein, Inc.
Naropin 5 mg/ml Epidural; Infiltration; Perineural Injection, Solution
NDC: 52584-286
Labeler:
General Injectables & Vaccines, Inc
Naropin 2 mg/ml Epidural; Infiltration; Perineural Injection, Solution
NDC: 63323-285
Labeler:
App Pharmaceuticals, LLC
Naropin 5 mg/ml Epidural; Infiltration; Perineural Injection, Solution
NDC: 63323-286
Labeler:
App Pharmaceuticals, LLC
Naropin 7.5 mg/ml Epidural; Perineural Injection, Solution
NDC: 63323-287
Labeler:
App Pharmaceuticals, LLC
Naropin 2 mg/ml Epidural; Infiltration Injection, Solution
NDC: 66298-2851
Labeler:
Fresenius Kabi Norge As
Naropin 2 mg/ml Epidural; Infiltration Injection, Solution
NDC: 66298-2852
Labeler:
Fresenius Kabi Norge As
Naropin 2 mg/ml Epidural; Infiltration Injection, Solution
NDC: 66298-2856
Labeler:
Fresenius Kabi Norge As